4.7 Review

Emerging trends in the nanomedicine applications of functionalized magnetic nanoparticles as novel therapies for acute and chronic diseases

期刊

JOURNAL OF NANOBIOTECHNOLOGY
卷 20, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s12951-022-01595-3

关键词

Magnetic nanoparticles; Si-RNA therapeutics; Vascular diseases; Neurological disorders; Nanomedicine

资金

  1. Uppsala University
  2. KIIT UNIVERSITY [BT/INF/22/SP42155/2021]

向作者/读者索取更多资源

This critical review focuses on the recent developments and therapeutic impact of functionalized magnetic nanoparticles (MNPs) in healthcare, with a special emphasis on COVID-19 testing and treatment. The limitations of traditional biosensors in healthcare emergencies are highlighted, and the potential of functionalized MNPs in treating various diseases is discussed. The review also provides insights into the future prospects of this field and its potential impact on the healthcare industry.
High-quality point-of-care is critical for timely decision of disease diagnosis and healthcare management. In this regard, biosensors have revolutionized the field of rapid testing and screening, however, are confounded by several technical challenges including material cost, half-life, stability, site-specific targeting, analytes specificity, and detection sensitivity that affect the overall diagnostic potential and therapeutic profile. Despite their advances in point-of-care testing, very few classical biosensors have proven effective and commercially viable in situations of healthcare emergency including the recent COVID-19 pandemic. To overcome these challenges functionalized magnetic nanoparticles (MNPs) have emerged as key players in advancing the biomedical and healthcare sector with promising applications during the ongoing healthcare crises. This critical review focus on understanding recent developments in theranostic applications of functionalized magnetic nanoparticles (MNPs). Given the profound global economic and health burden, we discuss the therapeutic impact of functionalized MNPs in acute and chronic diseases like small RNA therapeutics, vascular diseases, neurological disorders, and cancer, as well as for COVID-19 testing. Lastly, we culminate with a futuristic perspective on the scope of this field and provide an insight into the emerging opportunities whose impact is anticipated to disrupt the healthcare industry.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据